Broker Notes, Comments and Analysis

Broker notes, analysis and comments

Chesnara Plc: Another fine acquisition

Chesnara plc (LON:CSN) has announced its seventh acquisition in the Netherlands, buying the closed life insurance books of “Conservatrix”. The latter is a life insurance and mortgage provider that filed..

Fulham Shore: Platform ready for take-off

Fulham Shore plc (LON:FUL) has two restaurant brands, which are honed and proven in the sector. There is an opportunity to expand the estate to more than double its size..

Chesnara: Another fine acquisition

Chesnara plc (LONCSN) has announced its seventh acquisition in the Netherlands, buying the closed life insurance books of “Conservatrix”. The latter is a life insurance and mortgage provider that filed..

City of London Investment Group: Robust profits in tough markets

City of London Investment Group plc (LON:CLIG) has announced its trading update for the final quarter of FY’22. It has been another tough quarter for fund managers, with global markets..

Fintel core revenue growth is higher than Zeus forecast

Fintel plc (LON:FNTL), the leading provider of Fintech and support services to the UK retail financial services sector, has released a trading update for the six months to 30 June..

Shoe Zone analyst Zeus upgrades FY22 adjusted PBT forecast

Shoe Zone plc (LON:SHOE) Better than expected demand and further strong margin performance leads to an upgrade in FY22E adjusted PBT from “no less than £8.5m” to “no less than..

Shield Therapeutics: Looking to accelerate positive signals in the US

Shield Therapeutics plc (LON:STX) is a commercial-stage pharma company delivering specialty products that address patients’ unmet medical needs, with an initial focus on iron deficiency (ID). Following launch of Accrufer®..

Arbuthnot Banking Group: The power ranger of relationship deposit banking

Arbuthnot Banking Group plc (LON:ARBB) smashed expectations with underlying 1H’22 profits of £10.7m, which is more than we had forecast for the full year. This was driven by widening margins..

LBG Media “significant untapped growth opportunities” says Zeus

LBG Media plc (LON:LGB) confirms trading for the full year is to be ‘at least’ in line with current consensus, despite a challenging macro environment. The assured outlook reflects strong..

DWF Group “significant long-term upside” says Zeus

DWF Group plc (LON:DWF): A record year of strategic progress ¨ FY22 Results: Results were well flagged at a trading update in May. Net Revenue of £350.2m is +3.6% YOY,..

Pendragon trading on track says Zeus

Pendragon plc (LON:PDG)’s pre-close trading update for the first half of FY22 shows an expected underlying PBT of c. £33m (H1 FY21: £35.1m). This strong performance is in spite of..

Tissue Regenix: Strong 1H’22 sales suggest upside potential

Tissue Regenix Group plc (LON:TRX) is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL) and bone (BioRinse). It has a..

CentralNic analyst Zeus raise 2022 revenue forecast by 8% to $617m

CentralNic Group plc (LON:CNIC) LTM pro forma revenue growth accelerated again to 62% in Q2 2022, resulting in revenue of $335m and Adjusted EBITDA of $38m in H1. The company..

OnTheMarket analyst Zeus confident in forecasts

Foxtons, one of London’s leading estate agencies with more than 50 interconnected branches across London, has signed an agreement to advertise its UK residential sales and letting properties at OnTheMarket..

Kenmare Resources offers ‘strong value in under-supplied market’, Peel Hunt analyst

Kenmare Resources plc (LON:KMR) was the topic of conversation when DirectorsTalk caught up with Peel Hunt Mining Research Analyst Peter Mallin-Jones. Q1. How would you summarise the Q2 results? A1...

Cizzle Biotechnology: Considerable progress in first year since listing

Cizzle Biotechnology plc (LON:CIZ), focused on cancer diagnostics, was spun out of the University of York to exploit the biomarker, variant CIZ1b, for the early detection of different forms of..

Kenmare Resources: ‘increased production, pricing & shipments in H2’, Davy analyst (LON:KMR)

Kenmare Resources plc (LON:KMR) was the topic of conversation when DirectorsTalk caught up with Davy Research Analyst Colin Grant. Q1. What are the highlights from Kenmare’s Q2 production report? Firstly,..

Serinus Energy an important six months for the stock. Arden Partners thoughts

Serinus Energy plc (LON:SENX) is the topic of conversation when DirectorsTalk Interviews caught up with Daniel Slater, Analyst at Arden Partners to discuss the company. Daniel, what’s happening on the..

tinyBuild H1 performance was slightly ahead of expectations says Zeus

tinyBuild plc (LON:TBLD) H1 performance was slightly ahead of expectations despite sector indications of soft demand. The company continues to see strong demand from subscription services and its back catalogue..

Cizzle Biotechnology: Considerable progress in first year since listing

Cizzle Biotechnology plc (LON:CIZ), focused on cancer diagnostics, was spun out of the University of York to exploit the biomarker, variant CIZ1b, for the early detection of different forms of..

Search

Funds

Broker Notes, Comments and Analysis

Search

Funds

Broker Notes, Comments and Analysis

FTSE 100

Funds